Literature DB >> 7352840

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

D V Sheehan, J Ballenger, G Jacobsen.   

Abstract

Endogenous anxiety (anxiety hysteria, agoraphobia with panic attacks) is characterized by sudden, spontaneous panic attacks accompanied by multiple autonomic symptoms, overwhelming fear, a flight response, and polyphobic behavior. Psychotherapy, behavior therapy, and tranquillizers have been of limited success in treating this syndrome. Fifty-seven patients severely disabled by the syndrome for a mean period of 13 years completed the three-month study. Randomly assigned in a double-blind, placebo-controlled design to imipramine hydrochloride, pheneizine sulfate, or placebo, they were seen in supportive group therapy every two weeks. Patients in the pheneizine and imipramine cells showed significant improvement ovehe persistent trend for pheneizine to be superior to imipramine achieved significance only on the Work and Social Disability Scale and the Sympton Severity and Phobic Avoidance Scale. The implications for classification and theory are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7352840     DOI: 10.1001/archpsyc.1980.01780140053006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  56 in total

1.  Panic attacks and panic disorders.

Authors:  R Fontaine; P Beaudry
Journal:  Can Fam Physician       Date:  1984-06       Impact factor: 3.275

Review 2.  Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia.

Authors:  T A Furukawa; N Watanabe; R Churchill
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 3.  Serotonin selectivity for obsessive compulsive and panic disorders.

Authors:  S A Montgomery; T Bullock; N Fineberg
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

4.  Improved statistical analysis of moclobemide dose effects on panic disorder treatment.

Authors:  Donald C Ross; Donald F Klein; E H Uhlenhuth
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11-21       Impact factor: 5.270

Review 5.  Obstructive sleep apnea and severe mental illness: evolution and consequences.

Authors:  Wei-Chen Lin; John W Winkelman
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

6.  Psychiatric problem dismissed

Authors: 
Journal:  BMJ       Date:  1998-05-16

7.  Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine.

Authors:  R J Blanchard; J K Shepherd; R J Rodgers; L Magee; D C Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Beta-receptor responsiveness after desipramine treatment.

Authors:  R Pohl; G N Pandey; V K Yeragani; R Balon; J M Davis; R Berchou
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study.

Authors:  I M van Vliet; H G Westenberg; J A Den Boer
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Phobia: prevalence and risk factors.

Authors:  J H Boyd; D S Rae; J W Thompson; B J Burns; K Bourdon; B Z Locke; D A Regier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1990-11       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.